047. COVID-19: Treatment: Thursday, 12:15 - 1:30 p.m.
Poster Session: COVID-19: Treatment
Eriko Ogura, MD
Global Head of Drug Safety
Shionogi & Co., Ltd.
Osaka, Osaka, Japan
Noriko Nakagawa, n/a
Shionogi
Osaka, Osaka, Japan
Noriko Hayashi, n/a
Shionogi & Co., Ltd.
Osaka, Osaka, Japan
Eri Tsukimura, n/a
Shionogi Pharmacovigilance Center Co., Ltd.
Osaka, Osaka, Japan
Satoru Takashima, n/a
Shionogi & Co., Ltd.
Osaka, Osaka, Japan